| 2026 |
| 10/02 | (IR情報)15:30 連結子会社からの配当金受領に関するお知らせ |
| 10/02 | 4,763 | 4,790 | 4,700 | 4,700 | -2.75% | 1,177,400 | - | -1.76% |
| 10/01 | 4,833 | 4,866 | 4,752 | 4,833 | -0.45% | 1,040,900 | - | +0.9% |
| 09/30 | 4,820 | 4,866 | 4,735 | 4,855 | +0.91% | 1,494,600 | - | +1.36% |
| 09/29 | 4,851 | 4,859 | 4,774 | 4,811 | -2.24% | 1,241,300 | - | +0.4% |
| 09/28 | 4,944 | 4,982 | 4,914 | 4,921 | -0.69% | 1,267,900 | - | +2.56% |
| 09/25 | 4,958 | 5,003 | 4,921 | 4,955 | +1.08% | 1,189,600 | - | +3.34% |
| 09/25 | (空売り報告)Barclays Capital Securities Ltd 1,435,524株(0.49%)-0.07%義務消失 |
| 09/24 | 4,995 | 4,995 | 4,861 | 4,902 | -0.57% | 1,198,900 | - | +2.38% |
| 09/18 | 4,990 | 4,990 | 4,903 | 4,930 | -0.46% | 2,095,500 | - | +3.12% |
| 09/17 | 4,884 | 4,956 | 4,830 | 4,953 | +3.51% | 1,520,400 | - | +3.66% |
| 09/16 | (IR情報)15:00 早期アルツハイマー病治療剤「レケンビ」の皮下注製剤「レケンビ皮下注250 mgペン」、日本において承認取得 |
| 09/16 | 4,789 | 4,805 | 4,752 | 4,785 | +0.38% | 868,200 | - | +0.21% |
| 09/16 | (空売り報告)BNP Paribas Financial Markets SNC 2,317,184株(0.79%)-0.1% |
| 09/15 | 4,798 | 4,817 | 4,745 | 4,767 | +0.51% | 864,600 | - | -0.33% |
| 09/15 | (空売り報告)BNP Paribas Financial Markets SNC 2,603,414株(0.89%)+0.23% |
| 09/14 | 4,690 | 4,755 | 4,671 | 4,743 | +1.82% | 1,043,700 | - | -0.98% |
| 09/14 | (空売り報告)BNP Paribas Financial Markets SNC 1,936,514株(0.66%)+0.15% |
| 09/11 | 4,622 | 4,683 | 4,610 | 4,658 | -0.21% | 1,376,000 | - | -2.8% |
| 09/11 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 1,640,110株(0.56%)-0.06% |
| 09/10 | 4,599 | 4,668 | 4,592 | 4,668 | +1.04% | 1,345,400 | - | -2.61% |
| 09/10 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 1,817,310株(0.62%)+0.05% |
| 09/09 | 4,608 | 4,635 | 4,584 | 4,620 | -0.69% | 1,313,000 | - | -3.49% |
| 09/08 | 4,610 | 4,661 | 4,593 | 4,652 | +0.41% | 866,300 | - | -2.82% |
| 09/07 | 4,669 | 4,687 | 4,608 | 4,633 | -1.3% | 843,600 | - | -3.22% |
| 09/04 | 4,795 | 4,805 | 4,686 | 4,694 | -2.43% | 1,312,400 | - | -2.11% |
| 09/04 | (空売り報告)Barclays Capital Securities Ltd 1,634,659株(0.56%)再IN |
| 09/03 | (IR情報)13:00 「レケンビ」の皮下注射製剤、早期アルツハイマー病に対する初期療法として中国で承認取得 |
| 09/03 | 4,760 | 4,815 | 4,720 | 4,811 | +1.67% | 1,141,500 | - | +0.04% |
| 09/03 | (空売り報告)BNP Paribas Financial Markets SNC 1,489,247株(0.51%)再IN |
| 09/02 | 4,710 | 4,775 | 4,695 | 4,732 | -0.5% | 1,141,800 | - | -1.85% |
| 09/01 | 4,760 | 4,817 | 4,736 | 4,756 | +0.34% | 1,088,900 | - | -1.39% |
| 09/01 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 1,675,723株(0.57%)再IN |
| 08/31 | 4,754 | 4,795 | 4,721 | 4,740 | -1.74% | 2,105,200 | - | -1.72% |
| 08/31 | (空売り報告)Barclays Capital Securities Ltd 1,405,016株(0.48%)-0.06%義務消失 |
| 08/28 | 4,800 | 4,848 | 4,792 | 4,824 | +0.08% | 907,000 | - | +0.08% |
| 08/27 | 4,827 | 4,847 | 4,771 | 4,820 | -0.27% | 991,100 | - | +0.21% |
| 08/26 | 4,902 | 4,939 | 4,833 | 4,833 | -0.58% | 790,600 | - | +0.71% |
| 08/25 | 4,875 | 4,889 | 4,814 | 4,861 | +0.48% | 728,100 | - | +1.59% |
| 08/24 | 4,935 | 4,954 | 4,838 | 4,838 | -1.31% | 810,000 | - | +1.45% |
| 08/21 | 4,929 | 4,971 | 4,875 | 4,902 | -1.21% | 948,200 | - | +3.22% |
| 08/21 | (空売り報告)Barclays Capital Securities Ltd 1,600,646株(0.54%)-0.06% |
| 08/20 | 4,950 | 5,040 | 4,950 | 4,962 | +2.58% | 1,661,500 | - | +5.06% |
| 08/20 | (空売り報告)Barclays Capital Securities Ltd 1,754,781株(0.6%)+0.04% |
| 08/19 | 4,849 | 4,875 | 4,780 | 4,837 | +1.21% | 1,126,700 | - | +2.94% |
| 08/18 | 4,704 | 4,825 | 4,686 | 4,779 | +1.06% | 805,200 | - | +2.2% |
| 08/17 | 4,879 | 4,879 | 4,729 | 4,729 | -2.66% | 986,600 | - | +1.57% |
| 08/17 | (空売り報告)Barclays Capital Securities Ltd 1,653,281株(0.56%)-0.1% |
| 08/14 | 4,862 | 4,902 | 4,852 | 4,858 | -0.29% | 1,122,900 | - | +4.72% |
| 08/13 | 4,988 | 4,995 | 4,856 | 4,872 | -2.33% | 1,148,100 | - | +5.52% |
| 08/13 | (空売り報告)Barclays Capital Securities Ltd 1,931,481株(0.66%)-0.04% |
| 08/12 | 4,989 | 4,992 | 4,902 | 4,988 | +0.79% | 1,438,800 | - | +8.58% |
| 08/12 | (空売り報告)Barclays Capital Securities Ltd 2,053,881株(0.7%)+0.03% |
| 08/10 | 4,819 | 4,949 | 4,767 | 4,949 | +3.58% | 1,689,800 | - | +8.34% |
| 08/07 | 4,719 | 4,826 | 4,699 | 4,778 | +1.85% | 1,213,900 | - | +5.22% |
| 08/06 | 4,501 | 4,698 | 4,479 | 4,691 | +3.78% | 1,421,600 | - | +3.85% |
| 08/05 | 4,590 | 4,607 | 4,476 | 4,520 | -2.23% | 1,748,500 | - | +0.58% |
| 08/05 | (空売り報告)Barclays Capital Securities Ltd 1,958,681株(0.67%)-0.03% |
| 08/04 | 4,600 | 4,701 | 4,566 | 4,623 | -0.71% | 1,806,700 | - | +3.24% |
| 08/04 | (空売り報告)Barclays Capital Securities Ltd 2,045,181株(0.7%)+0.05% |
| 08/03 | (IR情報)15:30 2027年3月期第1四半期決算短信〔IFRS〕(連結) |
| 08/03 | (IR情報)15:30 2026年度(2027年3月期)第1四半期決算参考資料 |
| 08/03 | (IR情報)15:30 2026年度第1四半期決算説明会 |
| 08/03 | 4,807 | 4,816 | 4,538 | 4,656 | -3.56% | 2,274,700 | - | +4.42% |
| 08/03 | (空売り報告)Barclays Capital Securities Ltd 1,924,648株(0.65%)-0.06% |
| 07/31 | 4,900 | 4,947 | 4,805 | 4,828 | -4.03% | 2,497,600 | - | +8.94% |
| 07/30 | 5,057 | 5,132 | 4,897 | 5,031 | -1.55% | 2,428,300 | - | +14.42% |
| 07/30 | (空売り報告)Barclays Capital Securities Ltd 2,092,748株(0.71%)+0.1% |
| 07/29 | (IR情報)19:00 抗アミロイドβ抗体「レケンビ」の売上収益(速報)について |
| 07/29 | 4,861 | 5,110 | 4,846 | 5,110 | +6.66% | 3,429,200 | - | +17.44% |
| 07/28 | 4,766 | 4,816 | 4,750 | 4,791 | +0.8% | 1,836,300 | - | +11.37% |
| 07/27 | 4,649 | 4,786 | 4,636 | 4,753 | +2.08% | 2,045,100 | - | +11.39% |
| 07/27 | (空売り報告)Barclays Capital Securities Ltd 1,784,898株(0.61%)+0.04% |
| 07/24 | 4,597 | 4,678 | 4,563 | 4,656 | +1.62% | 1,441,600 | - | +9.99% |
| 07/23 | 4,550 | 4,585 | 4,515 | 4,582 | +0.7% | 1,202,400 | - | +8.97% |
| 07/22 | 4,450 | 4,607 | 4,440 | 4,550 | +1.52% | 1,564,000 | - | +8.98% |
| 07/21 | (5%ルール)アペリオ・グループ・エルエルシー(Aperio Group,…(0.12%)ブラックロック(ネザーランド)BV(BlackRock (Neth…(0.26%)ブラックロック(ルクセンブルグ)エス・エー(Black…(0.59%)ブラックロック・アセット・マネジメント・アイルラ…(1%)ブラックロック・アセット・マネジメント・カナダ・…(0.19%)ブラックロック・アドバイザーズ・エルエルシー(B…(0.18%)ブラックロック・インスティテューショナル・トラス…(1.2%)ブラックロック・インベストメント・マネジメント(…(0.76%)ブラックロック・ジャパン(1.92%)ブラックロック・ファンド・アドバイザーズ(Black…(1.9%)ブラックロック・ファンド・マネジャーズ・リミテッ…(0.25%)ブラックロック・フィナンシャル・マネジメント・イ…(0.12%) |
| 07/21 | 4,455 | 4,529 | 4,452 | 4,482 | +0.72% | 1,884,600 | - | +8.18% |
| 07/21 | (空売り報告)Barclays Capital Securities Ltd 1,667,998株(0.57%)-0.03% |
| 07/17 | 4,400 | 4,457 | 4,379 | 4,450 | +2.58% | 1,934,700 | - | +8.09% |
| 07/17 | (空売り報告)Barclays Capital Securities Ltd 1,755,998株(0.6%)+0.02% |
| 07/16 | 4,288 | 4,348 | 4,269 | 4,338 | +1.93% | 1,343,700 | - | +6.06% |
| 07/15 | 4,270 | 4,331 | 4,238 | 4,256 | -2.74% | 1,765,700 | - | +4.7% |
| 07/15 | (空売り報告)Barclays Capital Securities Ltd 1,705,398株(0.58%)-0.03% |
| 07/14 | 4,313 | 4,433 | 4,310 | 4,376 | +3.13% | 2,570,300 | - | +8.18% |
| 07/14 | (IR情報)8:30 抗Aβ抗体「レケンビ」の皮下注射製剤「LEQEMBI IQLIK」が早期アルツハイマー病に対する初期療法として米国FDAより承認取得 |
| 07/14 | (空売り報告)Barclays Capital Securities Ltd 1,782,798株(0.61%)+0.09% |
| 07/13 | 4,300 | 4,316 | 4,222 | 4,243 | -1.23% | 1,196,800 | - | +5.57% |
| 07/10 | 4,267 | 4,328 | 4,252 | 4,296 | +0.23% | 1,513,100 | - | +7.35% |
| 07/09 | 4,292 | 4,343 | 4,263 | 4,286 | -0.74% | 1,640,200 | - | +7.66% |
| 07/08 | 4,340 | 4,366 | 4,295 | 4,318 | +0.3% | 1,395,300 | - | +8.99% |
| 07/07 | 4,330 | 4,337 | 4,269 | 4,305 | -0.81% | 1,633,400 | - | +9.26% |
| 07/06 | (5%ルール)ノムラインターナショナルピーエルシー(NOMURA IN…(0%)野村アセットマネジメント(7.29%)野村證券(0.06%) |
| 07/06 | 4,305 | 4,352 | 4,280 | 4,340 | +2% | 1,289,000 | - | +10.71% |
| 07/03 | 4,301 | 4,342 | 4,242 | 4,255 | +1.6% | 1,598,200 | - | +9.13% |
| 07/02 | 4,175 | 4,188 | 4,114 | 4,188 | +1.92% | 1,778,100 | - | +7.72% |
| 07/01 | 4,065 | 4,129 | 4,050 | 4,109 | -0.24% | 1,072,700 | - | +5.98% |
| 06/30 | 4,167 | 4,170 | 4,110 | 4,119 | -0.63% | 1,818,900 | - | +6.32% |
| 06/30 | (空売り報告)JPM Securities Japan Co Ltd. 1,318,515株(0.45%)-0.12%義務消失 |
| 06/29 | 4,010 | 4,145 | 4,006 | 4,145 | +3.86% | 4,170,300 | - | +7.13% |
| 06/29 | (空売り報告)JPM Securities Japan Co Ltd. 1,673,211株(0.57%)再IN |
| 06/26 | 3,952 | 4,009 | 3,940 | 3,991 | +1.06% | 1,620,500 | - | +3.15% |
| 06/26 | (空売り報告)Barclays Capital Securities Ltd 1,541,312株(0.52%)再IN |
| 06/25 | 3,920 | 3,952 | 3,881 | 3,949 | +1.52% | 1,437,000 | - | +1.91% |
| 06/24 | 3,905 | 3,918 | 3,876 | 3,890 | -0.1% | 1,345,500 | - | +0.08% |
| 06/24 | (空売り報告)Barclays Capital Securities Ltd 1,125,812株(0.38%)-0.13%義務消失 |
| 06/23 | 3,903 | 3,947 | 3,894 | 3,894 | -0.18% | 1,736,100 | - | -0.18% |
| 06/22 | 3,861 | 3,908 | 3,822 | 3,901 | -0.03% | 1,395,000 | - | -0.59% |
| 06/19 | 3,900 | 3,944 | 3,872 | 3,902 | -1.69% | 2,438,200 | - | -1.09% |
| 06/19 | (空売り報告)Barclays Capital Securities Ltd 1,489,712株(0.51%)再IN |
| 06/18 | 3,888 | 3,976 | 3,881 | 3,969 | +3.66% | 2,448,700 | - | -0.23% |
| 06/17 | 3,857 | 3,886 | 3,813 | 3,829 | +2.11% | 1,988,700 | - | -4.47% |
| 06/16 | 3,796 | 3,799 | 3,719 | 3,750 | -1.86% | 1,702,600 | - | -7.27% |
| 06/15 | 3,794 | 3,840 | 3,779 | 3,821 | +1.08% | 1,728,800 | - | -6.35% |
| 06/12 | 3,754 | 3,790 | 3,725 | 3,780 | +1.53% | 1,735,600 | - | -8.1% |
| 06/11 | 3,709 | 3,739 | 3,660 | 3,723 | -0.45% | 1,960,900 | - | -10.25% |
| 06/10 | 3,736 | 3,749 | 3,706 | 3,740 | -0.08% | 1,955,700 | - | -10.7% |
| 06/09 | 3,765 | 3,784 | 3,735 | 3,743 | -1.66% | 1,811,900 | - | -11.41% |
| 06/08 | 3,800 | 3,866 | 3,772 | 3,806 | +0.82% | 1,696,200 | - | -10.72% |
| 06/05 | 3,850 | 3,856 | 3,767 | 3,775 | -1.05% | 1,769,400 | - | -12.11% |
| 06/04 | (IR情報)12:00 無担保社債の発行について |
| 06/04 | 3,829 | 3,853 | 3,785 | 3,815 | +1.49% | 1,753,400 | - | -11.83% |
| 06/03 | 3,800 | 3,818 | 3,719 | 3,759 | -1.55% | 2,179,400 | - | -13.86% |
| 06/02 | 3,793 | 3,853 | 3,737 | 3,818 | +0.26% | 2,323,400 | - | -13.29% |
| 06/01 | 3,958 | 3,963 | 3,808 | 3,808 | -4.42% | 2,342,900 | - | -14.31% |
| 05/29 | 3,901 | 3,994 | 3,901 | 3,984 | +2.13% | 3,394,200 | - | -11.19% |
| 05/28 | 4,032 | 4,057 | 3,901 | 3,901 | -3.51% | 2,698,800 | - | -13.75% |
| 05/27 | 3,980 | 4,068 | 3,973 | 4,043 | +1.58% | 2,164,800 | - | -11.4% |
| 05/26 | 4,101 | 4,104 | 3,952 | 3,980 | -3.93% | 3,438,800 | - | -13.52% |
| 05/25 | (IR情報)15:30 「経営戦略説明会」資料 |
| 05/25 | 4,158 | 4,178 | 4,120 | 4,143 | -0.34% | 1,783,500 | - | -10.79% |
| 05/22 | (5%ルール)BlackRock Financial Management,Inc.(0.1%)BlackRock Fund Managers Limited(0.25%)BlackRock Investment Management(UK)Limited(0.65%)BlackRock(Luxembourg)S.A.(0.6%)BlackRock(Netherlands)BV(0.27%)アペリオ・グループ・エルエルシー(Aperio Group,…(0.19%)ブラックロック・アセット・マネジメント・アイルラ…(0.99%)ブラックロック・アセット・マネジメント・カナダ・…(0.18%)ブラックロック・アドバイザーズ・エルエルシー(0.16%)ブラックロック・インスティテューショナル・トラス…(1.17%)ブラックロック・ジャパン(1.92%)ブラックロック・ファンド・アドバイザーズ(2.11%) |
| 05/22 | 4,220 | 4,249 | 4,157 | 4,157 | -2.03% | 2,045,300 | - | -11.02% |
| 05/21 | 4,298 | 4,298 | 4,206 | 4,243 | -0.05% | 1,851,200 | - | -9.8% |
| 05/20 | 4,466 | 4,470 | 4,231 | 4,245 | -4.95% | 2,678,300 | - | -10.35% |
| 05/19 | 4,429 | 4,512 | 4,426 | 4,466 | +0.84% | 1,727,000 | - | -6.41% |
| 05/18 | 4,513 | 4,529 | 4,351 | 4,429 | -6.22% | 2,716,800 | - | -7.71% |
| 05/15 | (IR情報)15:45 株式報酬制度(役員報酬BIP信託)の継続に伴う自己株式処分に関するお知らせ |
| 05/15 | (IR情報)15:40 株式報酬制度(役員報酬BIP信託)の継続に関するお知らせ |
| 05/15 | (IR情報)15:30 2026年3月期決算短信〔IFRS〕(連結) |
| 05/15 | (IR情報)15:30 2025年度(2026年3月期)通期決算参考資料 |
| 05/15 | (IR情報)15:30 2025年度決算説明会資料 |
| 05/15 | 4,710 | 4,739 | 4,615 | 4,723 | +0.04% | 1,652,100 | - | -2.15% |
| 05/14 | 4,726 | 4,748 | 4,664 | 4,721 | +0.08% | 1,216,700 | - | -2.52% |
| 05/13 | 4,719 | 4,736 | 4,653 | 4,717 | +1.46% | 1,116,100 | - | -2.86% |
| 05/12 | 4,690 | 4,737 | 4,639 | 4,649 | +0.06% | 964,500 | - | -4.5% |
| 05/11 | 4,607 | 4,669 | 4,511 | 4,646 | -0.66% | 1,495,000 | - | -4.93% |